Jpmorgan Chase & CO Conformis Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.28 - $0.65 $2,433 - $5,649
-8,691 Reduced 9.04%
87,497 $31,000
Q1 2022

May 11, 2022
BUY
$0.56 - $0.83 $131 - $194
234 Added 0.24%
96,188 $60,000
Q4 2021

Feb 10, 2022
SELL
$0.67 - $1.32 $330 - $650
-493 Reduced 0.51%
95,954 $73,000
Q3 2021

Nov 12, 2021
BUY
$1.02 - $1.83 $98,375 - $176,498
96,447 New
96,447 $128,000

Others Institutions Holding CFMS

# of Institutions
2
Shares Held
5.79K
Call Options Held
0
Put Options Held
0
View Full List

About Conformis Inc

CFMS Quotes by TradingView
  • Ticker CFMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 187,856,992
  • Description
  • Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...
More about CFMS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email